Evaluating product safety with accepted medical and laboratory biomarkers
Solutions: Recruitment of healthy participants or those with various health conditions
Assessment of safety based on different clinical and laboratory measurements (e.g., body weight, vital signs, comprehensive metabolic panel, hematology panel, gastrointestinal symptoms)
Assessment, categorization, and coding of adverse events by in-house physicians
Partnerships with academic sites for emerging biomarkers (hormones, oxidative stress and inflammation markers, etc.)
Since 2006, Biofortis has completed many clinical trials related to safety.
